The standardized mortality rate for pancreatic malignant neoplasms in Brazil among men is projected to increase from 12.0 in 2024 to 13.3 per hundred thousand by 2028. Comparing the forecasted data with the base year, 2023, there's an anticipated compound annual growth rate (CAGR) of approximately 2.6%. This growth reflects an ongoing increasing trend in mortality rates, suggesting potential public health challenges.
Future trends to watch for include advancements in medical technology and treatments, government health policy changes, public awareness campaigns about risk factors, and research into genetic predispositions. These factors may alter the projected trend, either alleviating or exacerbating the forecasted mortality rates.
